Have an account? Log in.
I don't have an account.
Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $100 to $95.
Rothschild & Co analyst Edward Lewis upgrades Colgate-Palmolive (NYSE:CL) from Neutral to Buy and raises the price target from $93 to $100.
JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $97 to $95.
Barclays analyst Lauren Lieberman maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from $88 to $79.
B of A Securities analyst Bryan Spillane maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $105 to $102.
Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Equal-Weight and lowers the price target from $100 to $92.
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $96 to $92.
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $100 to $98.
Deutsche Bank analyst Steve Powers upgrades Colgate-Palmolive (NYSE:CL) from Hold to Buy and raises the price target from $90 to $98.